Developing Biomarker Assays With Commercialisation in Mind
Time: 3:10 pm
day: Day 1 - Track B (1)
Details:
- Many therapeutics require co-development of a diagnostic test to select and enrich for biomarker-positive patient populations
- Discovery’s approach of utilising laboratory-developed tests to support early phase development permits rapid development and deployment to support patient management
- We will present a brief overview of the Discovery process with an emphasis on regulatory compliance and commercial foresight if a regulated CDx is required
